Share your research across all three days of ISCN 2027 — and compete for the Young Investigator Awards. Open submission, peer-reviewed, with the strongest posters presenting live on the final day.
All submissions are peer-reviewed by the ISCN Scientific Committee. Notification and final-materials dates confirmed once the review schedule is set.
You don't need to register to submit. Anyone can put their work forward. If your poster is accepted, you'll confirm your place by registering at the standard rate.
Send your poster for peer review — no registration or payment required to apply.
The Scientific Committee evaluates every submission against the published rubric.
If accepted, register at the standard rate by the confirmation deadline to claim your place.
Show your poster at ISCN 2027 — and join the official program.
What you agree to: by submitting, you confirm that if accepted you'll register at the standard rate by the stated deadline to present. Accepted posters not confirmed by the deadline are released so the place can go to someone else.
The poster track is the heart of ISCN's open science — and the home of the Young Investigator Awards. It's especially suited to students, residents, and early-career researchers, but open to anyone with work to show. Posters are displayed across all three days, judged throughout, and the strongest become finalists.
Poster submissions are eligible for the Young Investigator Awards. Posters are assessed across the congress; finalists are selected, and the top three present live on the final day before the winners are named at the Closing Ceremony.
A poster represents a body of research, so we capture the full author team and the study behind it. Have these ready before you start.
We welcome new science and well-made clinical teaching — but not anecdote or product promotion without an evidence basis. Every accepted poster can answer one question: what is this built on?
Every eligible poster competes for the Young Investigator Awards — recognition and publication-fee waivers for the strongest early-career work.
“Presented at the 9th International Symposium on Clinical Neuroscience” — a real line on your CV.
Accepted work is eligible for publication through our proceedings partnership with an international journal with IF.
Feedback from the ISCN Scientific Committee — valuable in itself, whatever the outcome.
Listed in the official program and app as a contributor — not just an attendee.
Meet the clinicians and researchers shaping the field, as one of them.
Every eligible poster competes for the Young Investigator Awards. Posters are assessed across the congress; the strongest become finalists, and the top three present live on the final day before the winners are named at the Closing Ceremony.
Eligibility — who counts as an early-career investigator — is confirmed in the submission guidelines.
A few things worth knowing up front — so there are no surprises after acceptance.
You'll receive the size and format specification (dimensions, orientation, and whether printed or digital) on acceptance. Build to spec.
Posters are shown throughout the congress and assessed during dedicated poster sessions — maximum visibility for your work.
If selected as a finalist, you'll present live on the final day before the Young Investigator winners are named. Be ready to stand by your work.
The presenting author should be available during poster-assessment windows to discuss the work with judges and attendees.
Please hold all conference dates; poster sessions and the finalist round are scheduled across the congress.
If accepted, you commit to register and present. Accepted posters not confirmed by the deadline are released.
Mirror this structure and you'll be in good shape. Up to 500 words, four parts, plus your references and disclosure. This example is fictitious — for format only.
Heart-Rate Variability Biofeedback as an Adjunct in Persistent Post-Concussion Dizziness: A Pilot Study
Autonomic dysregulation is increasingly implicated in persistent post-concussion symptoms, yet targeted autonomic interventions remain underused in vestibular rehabilitation. We examined whether heart-rate variability (HRV) biofeedback, added to standard vestibular therapy, improves dizziness outcomes.
Thirty adults with post-concussion dizziness persisting beyond 12 weeks were assigned to standard vestibular rehabilitation alone or with 6 weeks of daily HRV biofeedback. Outcomes were the Dizziness Handicap Inventory (DHI) and resting HRV, measured at baseline and 6 weeks.
The biofeedback group showed a greater mean DHI reduction (−22.4 vs −11.8 points) and a larger increase in resting HRV. Differences were consistent across age groups; no adverse events were reported.
Adding HRV biofeedback to vestibular rehabilitation may accelerate recovery from persistent post-concussion dizziness. Findings are preliminary and warrant a larger controlled trial.
Every eligible poster is automatically considered. Eligibility centers on early-career investigators — students, residents, and recent graduates. Specific criteria are in the submission guidelines.
Yes. Upto TWO submissions are welcome — submit each separately. You're also welcome to submit a microlearning talk.
No — submission is open to all. But if accepted, you'll register at the standard rate to present.
You'll get the exact format and dimensions specification on acceptance, so you can build to spec. Don't print before then.
The ISCN Scientific Committee, against a published rubric: rigor, relevance, originality, translational impact, and clarity.
Yes. You retain your work; submitting grants ISCN permission to include it in the program and any recording.
As posters clear peer review, they're announced here. Submit early and see your work join the list.
Submissions open 15 July 2026. Accepted posters — presenting author, affiliation, and title — will appear here as the Scientific Committee completes its review. Submitters consent to being listed when they apply.
Put your research in front of the field — and in the running for the Young Investigator Awards. Start your poster submission today.